ZIOPHARM ONCOLOGY INC's ticker is and the CUSIP is 98973P901. A total of 3 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33 | -54.8% | 257,300 | +79.6% | 0.00% | – |
| Q2 2023 | $73 | -46.3% | 143,300 | -34.1% | 0.00% | – |
| Q1 2023 | $136 | -15.5% | 217,300 | -12.9% | 0.00% | – |
| Q4 2022 | $161 | -100.0% | 249,400 | -28.1% | 0.00% | -100.0% |
| Q3 2022 | $596,000 | +254.8% | 346,800 | +155.4% | 0.00% | – |
| Q2 2022 | $168,000 | +180.0% | 135,800 | +46.8% | 0.00% | – |
| Q1 2022 | $60,000 | +650.0% | 92,500 | -49.2% | 0.00% | – |
| Q4 2021 | $8,000 | -95.5% | 182,100 | +177.2% | 0.00% | – |
| Q3 2021 | $179,000 | +16.2% | 65,700 | +12.5% | 0.00% | – |
| Q2 2021 | $154,000 | +17.6% | 58,400 | +15900.0% | 0.00% | – |
| Q1 2021 | $131,000 | -70.6% | 365 | -79.4% | 0.00% | -100.0% |
| Q4 2020 | $446,000 | +281.2% | 1,773 | +280.5% | 0.00% | – |
| Q3 2020 | $117,000 | -63.2% | 466 | -52.0% | 0.00% | -100.0% |
| Q2 2020 | $318,000 | +32.0% | 970 | -1.4% | 0.00% | – |
| Q1 2020 | $241,000 | -35.2% | 984 | +24.7% | 0.00% | -100.0% |
| Q4 2019 | $372,000 | -37.3% | 789 | -43.1% | 0.00% | -50.0% |
| Q3 2019 | $593,000 | +43.6% | 1,387 | +95.6% | 0.00% | +100.0% |
| Q2 2019 | $413,000 | +334.7% | 709 | +184.7% | 0.00% | – |
| Q1 2019 | $95,000 | -74.0% | 249 | -87.3% | 0.00% | -100.0% |
| Q4 2018 | $365,000 | +812.5% | 1,954 | +1450.8% | 0.00% | – |
| Q3 2018 | $40,000 | -52.4% | 126 | -55.2% | 0.00% | – |
| Q2 2018 | $84,000 | +1100.0% | 281 | +93.8% | 0.00% | – |
| Q1 2018 | $7,000 | -46.2% | 145 | -69.8% | 0.00% | -100.0% |
| Q4 2017 | $13,000 | +85.7% | 480 | +25.3% | 0.00% | – |
| Q3 2017 | $7,000 | -50.0% | 383 | -52.9% | 0.00% | -100.0% |
| Q2 2017 | $14,000 | -77.0% | 814 | +17.0% | 0.00% | -66.7% |
| Q1 2017 | $61,000 | +52.5% | 696 | +25.6% | 0.00% | +50.0% |
| Q4 2016 | $40,000 | -47.4% | 554 | -56.2% | 0.00% | -60.0% |
| Q3 2016 | $76,000 | +46.2% | 1,265 | +39.3% | 0.01% | +66.7% |
| Q2 2016 | $52,000 | -7.1% | 908 | -8.4% | 0.00% | -25.0% |
| Q1 2016 | $56,000 | -31.7% | 991 | +31.3% | 0.00% | -33.3% |
| Q4 2015 | $82,000 | -50.6% | 755 | -16.4% | 0.01% | -50.0% |
| Q3 2015 | $166,000 | -44.7% | 903 | +24.2% | 0.01% | -52.0% |
| Q2 2015 | $300,000 | -48.7% | 727 | -38.0% | 0.02% | -63.2% |
| Q1 2015 | $585,000 | +1989.3% | 1,173 | +676.8% | 0.07% | +2166.7% |
| Q4 2014 | $28,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 257,300 | $33 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 91,400 | $12,042 | 0.00% |